FDA Inspection 1065580 — aap Biomaterials, GmbH
The FDA completed an inspection of aap Biomaterials, GmbH on September 6, 2018 in Dieburg. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 6, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Dieburg (Germany)
Citations
| ID | CFR | Description |
|---|---|---|
| 14712 | 21 CFR 820.184 | DHR - not or inadequately maintained |
| 14716 | 21 CFR 820.30(f) | Design verification - output does not meet input requirement |
| 3433 | 21 CFR 820.75(c) | Process changes - review, evaluation and revalidation |
| 631 | 21 CFR 803.17(a)(1) | Lack of System for Event Evaluations |